Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study
Year: 2007
Type: article
Source: Blood
Institutions: Université Paris-Sud, Inserm, Institut Gustave Roussy, Hôpital Avicenne
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2082183475
